Seroquel is an FDA approved drug to treat schizophrenia and bipolar disorder. Doctors have also prescribed Seroquel for many off label uses including insomnia, depression, and Post-Traumatic Stress Disorder (PTSD). Unfortunately, Seroquel users have experienced an increased risk of diabetes. Injured victims have filed over 7,000 Seroquel lawsuits in federal court against AstraZeneca, Seroquel’s manufacturer. One legal expert predicts that AstraZeneca’s defense costs will reach $10 billion.

Seroquel MDL Lawsuits

In 2006, the U.S. Judicial Panel on Multidistrict Litigation (MDL) held that all lawsuits against AstraZeneca will be centralized in the U.S. District Court for the Middle District of Florida. An MDL proceeding is common when multiple plaintiffs file lawsuits against a defendant with common issues of fact and law. The lawsuits’ costs are significantly reduced

because the discovery phase of litigation occurs once and not for every individual lawsuit. An MDL proceeding is also an efficient way of litigating multiple individual lawsuits and could lead to quicker verdicts and settlements for injured victims.

Seroquel Class Action Lawsuit

A class action lawsuit against AstraZeneca has been filed in the U.S. District Court in Florida. Seroquel lawyers are representing Seroquel users who developed diabetes. The Seroquel class action lawsuit alleges that AstraZeneca was aware that Seroquel may cause diabetes and that the company failed to warn doctors and patients. In addition to compensatory and punitive damages, the Seroquel lawsuit also seeks a court order requiring AstraZeneca to establish a medical monitoring fund. The fund would pay for Seroquel users to be tested for diabetes and other blood sugar disorders.

Seroquel Lawsuit: Illegal Marketing

Many Seroquel lawsuits allege that AstraZeneca actively marketed Seroquel for off-label uses. It is illegal to market drugs for non-FDA approved uses. AstraZeneca disclosed in its 2006 annual report that the Philadelphia U.S. Attorney’s Office is investigating allegations that AstraZeneca promoted Seroquel for off-label uses.  

Seroquel lawsuits also allege that AstraZeneca’s marketing department misrepresented the diabetes risk linked to Seroquel use. On November 16, 2006, the FDA’s Department of Health and Human Services sent AstraZeneca a letter stating that AstraZeneca’s marketing department violated the Federal Food, Drug, and Cosmetic Act. The letter alleges that AstraZeneca provided false and misleading information by minimizing Seroquel’s link to diabetes.    

File a Seroquel Lawsuit

If you or a loved one has been injured by Seroquel, please contact us today. Our Seroquel lawyers can help you file a potential lawsuit to recover compensation for your injuries.

  • Bernstein Liebhard LLP is no longer accepting Seroquel cases.

Published November 17, 2011 by